FDA Approves Sientra’s Low Plus Profile Projection Breast ImplantFDA Approves Sientra’s Low Plus Profile Projection Breast Implant

FDA Approves Sientra’s Low Plus Profile Projection Breast Implant

3 years ago

New Implant Offers Surgeons and Their Patients More Options to Customize Their Surgical OutcomesSANTA BARBARA, Calif., July 06, 2022 (GLOBE…

Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in OhioSurgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio

Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio

3 years ago

This marks the second medical facility to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR)…

Qualigen Therapeutics Announces Partnership with Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies for QN-302Qualigen Therapeutics Announces Partnership with Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies for QN-302

Qualigen Therapeutics Announces Partnership with Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies for QN-302

3 years ago

CARLSBAD, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on…

Ozop Energy Solutions, Inc. to Report Substantial Revenue Growth for Q2 2022 Over 2021Ozop Energy Solutions, Inc. to Report Substantial Revenue Growth for Q2 2022 Over 2021

Ozop Energy Solutions, Inc. to Report Substantial Revenue Growth for Q2 2022 Over 2021

3 years ago

Warwick, NY, July 06, 2022 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. Inc. (OZSC), is pleased to announce that it expects…

TELUS Health reaches milestone – supports two million Canadians with access to their own digital personal health recordTELUS Health reaches milestone – supports two million Canadians with access to their own digital personal health record

TELUS Health reaches milestone – supports two million Canadians with access to their own digital personal health record

3 years ago

Since launching in Western Canada in 2019, TELUS Health’s Personal Health Record (PHR) solution has seen rapid growth helping more…

Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid CancersSheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers

Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers

3 years ago

First clinical trial of Allocetra™ in patients with cancer builds upon promising preclinical studies demonstrating its broadly applicable immunotherapeutic effects…

The Lancet Gastroenterology & Hepatology Publishes Data from Albireo’s Landmark PEDFIC 1 Study of Bylvay® (odevixibat) Treatment in PFICThe Lancet Gastroenterology & Hepatology Publishes Data from Albireo’s Landmark PEDFIC 1 Study of Bylvay® (odevixibat) Treatment in PFIC

The Lancet Gastroenterology & Hepatology Publishes Data from Albireo’s Landmark PEDFIC 1 Study of Bylvay® (odevixibat) Treatment in PFIC

3 years ago

First successful global gold standard pediatric Phase 3 trial ever conducted in cholestatic liver disease PEDFIC 1 & 2 studies…

POINT Biopharma to Participate in Upcoming Investor ConferencesPOINT Biopharma to Participate in Upcoming Investor Conferences

POINT Biopharma to Participate in Upcoming Investor Conferences

3 years ago

INDIANAPOLIS, July 06, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating…

T2 Biosystems Announces Preliminary Second Quarter 2022 Financial ResultsT2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results

T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results

3 years ago

Implemented expense reductions including headcount during the second quarterLEXINGTON, Mass., July 06, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO),…

Zacks Places Share Value of ABVC BioPharma at $9.50Zacks Places Share Value of ABVC BioPharma at $9.50

Zacks Places Share Value of ABVC BioPharma at $9.50

3 years ago

FREMONT, CA, July 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical…